CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Open platformOpen platform

Curis Prices $8.5 Million Private Placement

By Public Technologies
  • Curis priced an $8.5 million private placement with existing healthcare-focused institutional investors, expected to close around October 19, 2026.
  • The offering comprises 16,666,680 common shares or pre-funded warrants at $0.51 each, including an accompanying common warrant.
  • Common warrants cover 16,666,680 shares at $0.60 each, becoming exercisable after six months and expiring five-and-a-half years from issuance.
  • Existing January 2026 and August 2026 warrants will have exercise prices reduced to $0.60 from $15 and $1.75, respectively.
  • Proceeds will fund research and operations through initial chronic lymphocytic leukemia data from 5-10 patients expected in December 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Curis Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610160800PR_NEWS_USPR_____NE74019) on October 16, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk